What this test measures
This rapid lateral-flow test detects hepatitis B envelope antigen (HBeAg) in a drop of serum or plasma. HBeAg is a soluble protein released by actively replicating HBV; its presence usually correlates with high HBV DNA levels and high infectivity.
Results are visible in 15–20 minutes. The test is used as a quick triage tool in clinical practice; quantitative HBV DNA PCR remains the gold standard for measuring viral replication.
Why it matters
For the estimated 40 million Indians living with chronic hepatitis B, HBeAg status is an important staging marker. HBeAg-positive patients are usually in a high-replication phase with greater infectivity — relevant for sexual partners, household contacts, and especially mother-to-child transmission, where HBeAg-positive mothers transmit HBV to over 80% of unprotected infants.
Rapid HBeAg is used during pregnancy workup, in chronic HBV monitoring visits, and in occupational/exposure assessment. A positive result triggers HBV DNA quantitative testing to confirm viral load and HBeAg ELISA confirmation. AASLD/EASL guidelines use HBeAg, anti-HBe, HBV DNA, and ALT together to phase chronic HBV and decide treatment.
How to prepare
No fasting required. The test uses serum or plasma. Bring any prior HBV reports (HBsAg, HBV DNA, liver enzymes) for context.
Markers & reference ranges
Reference ranges below are typical adult values. Your lab's reported range may differ slightly based on the assay platform and patient demographics — always read your report against the range printed on it.
| Marker | Normal range | If low | If high |
|---|---|---|---|
| HBeAg (Rapid) (Reactive / Non-reactive)[1][2] | Non-reactive (Negative) | Non-reactive — HBeAg not detected. In chronic HBV this can mean inactive carrier phase, HBeAg-negative chronic hepatitis (mutant virus), or resolved infection. HBV DNA and ALT tell you which. | Reactive — HBeAg detected. Indicates active HBV replication and high infectivity. Confirm with quantitative HBV DNA. In pregnancy, antiviral therapy (tenofovir) is usually offered in the third trimester to reduce mother-to-child transmission. |
HBeAg status vs chronic HBV phase
| Phase | HBeAg | Anti-HBe | HBV DNA | ALT |
|---|---|---|---|---|
| Immune-tolerant | Positive | Negative | Very high | Normal |
| HBeAg-positive chronic hepatitis | Positive | Negative | High | Raised |
| Inactive carrier | Negative | Positive | Low (<2000 IU/mL) | Normal |
| HBeAg-negative chronic hepatitis | Negative | Positive | Variable | Raised |
| Resolved infection | Negative | Positive | Undetectable | Normal |
Frequently asked questions
I am HBsAg-positive and HBeAg-positive. Am I more infectious?
Yes — HBeAg-positive patients usually have high HBV DNA levels and are more infectious to sexual partners, household contacts, and unprotected infants. HBV DNA quantitative gives the exact viral load.
I am pregnant and HBeAg-positive. What is the risk to my baby?
Without intervention, transmission rates exceed 80% in HBeAg-positive mothers. With timely birth-dose HBV vaccine + hepatitis B immunoglobulin within 12 hours, plus antiviral therapy (tenofovir) in the third trimester if viral load is high, transmission can be reduced to under 5%.
Does HBeAg-negative mean I do not need treatment?
Not always. HBeAg-negative chronic hepatitis B is a recognised phase where the virus replicates despite HBeAg being negative. HBV DNA and ALT levels decide treatment, not HBeAg alone.
How accurate is the rapid HBeAg test compared to ELISA?
Rapid HBeAg has ~90–95% sensitivity and >95% specificity. For treatment decisions, confirm with ELISA/CLIA HBeAg and run quantitative HBV DNA.
Why did my HBeAg become negative over time?
In natural history, HBeAg seroconversion (loss of HBeAg, gain of anti-HBe) happens at a rate of 5–10% per year. It usually accompanies a drop in HBV DNA and improvement in liver enzymes.
Is HBeAg-positive chronic HBV always treated?
Not always. Immune-tolerant phase (HBeAg-positive, very high DNA, normal ALT) is usually monitored. HBeAg-positive chronic hepatitis (raised ALT) is treated. Decisions are individualised by hepatologists.
Will antivirals cure my hepatitis B?
Current antivirals (tenofovir, entecavir) suppress the virus and prevent progression but are not yet curative. Functional cure (HBsAg loss) happens in a small percentage of treated patients per year. New therapies are in clinical trials.
Related Hepatitis tests
Tests commonly ordered alongside HEPATITIS B ENEVELOPE ANTIGEN(HBEAG) RAPID TEST, or that help interpret an unexpected result.
Sources & references
- AASLD HBV Guidance 2018 · accessed 2026-05-30T00:00:00.000Z
- EASL 2017 Clinical Practice Guidelines on HBV · accessed 2026-05-30T00:00:00.000Z
- CDC — Hepatitis B Serology · accessed 2026-05-30T00:00:00.000Z
- WHO — Hepatitis B Fact Sheet · accessed 2026-05-30T00:00:00.000Z
Book with Zelnoo
Get your HEPATITIS B ENEVELOPE ANTIGEN(HBEAG) RAPID TEST test done at home — transparent prices, NABL-accredited labs.
Zelnoo lets you compare diagnostic test prices across NABL-accredited labs in Mumbai & Thane, book a free home phlebotomist visit, and receive digital reports in 24–48 hours into a consent-first report vault. No subscriptions, no membership fees — pay only for the test you book.
Book HEPATITIS B ENEVELOPE ANTIGEN(HBEAG) RAPID TEST now